Therapeutic progress--Review III. Can drugs prevent recurrent myocardial infarction?

A long-term prevention study with oxprenolol in coronary heart disease.

The New England journal of medicine·1982

Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.

Acta endocrinologica·1976

Anabolic steroids in athelics: crossover double-blind trial on weightlifters.

British medical journal·1975

Effect of rifampicin and isoniazid on liver function.

British medical journal·1972

Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.

Journal of clinical and hospital pharmacy·1986

A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.

Journal of clinical and hospital pharmacy·1986

Therapeutic progress--review XXIII. Are we making progress in the treatment of acute stroke?

Journal of clinical and hospital pharmacy·1986

Therapeutic progress--review XXIII. Morphine analgesia in terminal care.

Journal of clinical and hospital pharmacy·1986

Recent advances in pharmaceutical chemistry--review II. Histamine H2-receptor antagonists.

Journal of clinical and hospital pharmacy·1986

Doctors' knowledge of the cost of common medications.

Journal of clinical and hospital pharmacy·1986

Positive allosteric modulator of SERCA pump NDC-1171 attenuates cardiac functional decline in mouse model of Duchenne muscular dystrophy.

Function (Oxford, England)·2026

Clinical Impact of Diagnostic Delay by Red Flags Assessment in Transthyretin Amyloid Cardiomyopathy.

JACC. Advances·2026

Cardiometabolic and ASCVD Risk Profiles in Arab Americans: Insights From the SALAM Registry.

JACC. Advances·2026

The Association of Social Vulnerability With Maternal and Fetal Outcomes in a Cardio-Obstetrics Cohort.

JACC. Advances·2026

Vitamin D Pathway Activation Reduces Cardiomyocyte DNA Damage and Improves Cardiac Contractility in Preclinical Models.

JACC. Advances·2026

Acute Coronary Syndrome After High-Voltage Electrocution: A Shocking Diagnosis.

JACC. Case reports·2026

Related Experiment Videos

Therapeutic progress--Review III. Can drugs prevent recurrent myocardial infarction?

Related Concept Videos

A long-term prevention study with oxprenolol in coronary heart disease.

Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.

Anabolic steroids in athelics: crossover double-blind trial on weightlifters.

Effect of rifampicin and isoniazid on liver function.

Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.

A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.

Therapeutic progress--review XXIII. Are we making progress in the treatment of acute stroke?

Therapeutic progress--review XXIII. Morphine analgesia in terminal care.

Recent advances in pharmaceutical chemistry--review II. Histamine H2-receptor antagonists.

Doctors' knowledge of the cost of common medications.

Positive allosteric modulator of SERCA pump NDC-1171 attenuates cardiac functional decline in mouse model of Duchenne muscular dystrophy.

Clinical Impact of Diagnostic Delay by Red Flags Assessment in Transthyretin Amyloid Cardiomyopathy.

Cardiometabolic and ASCVD Risk Profiles in Arab Americans: Insights From the SALAM Registry.

The Association of Social Vulnerability With Maternal and Fetal Outcomes in a Cardio-Obstetrics Cohort.

Vitamin D Pathway Activation Reduces Cardiomyocyte DNA Damage and Improves Cardiac Contractility in Preclinical Models.

Acute Coronary Syndrome After High-Voltage Electrocution: A Shocking Diagnosis.

Related Experiment Videos

Therapeutic progress--Review III. Can drugs prevent recurrent myocardial infarction?

Related Concept Videos

Related Articles